|
CIC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.686100E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.245900E-02 |
| Normal-vs-Stage2 |
6.383500E-02 |
| Normal-vs-Stage3 |
2.759900E-02 |
| Normal-vs-Stage4 |
2.026000E-01 |
| Stage1-vs-Stage2 |
8.420600E-01 |
| Stage1-vs-Stage3 |
7.971400E-01 |
| Stage1-vs-Stage4 |
5.261200E-01 |
| Stage2-vs-Stage3 |
9.912200E-01 |
| Stage2-vs-Stage4 |
5.065000E-01 |
| Stage3-vs-Stage4 |
4.338200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.706100E-02 |
| Normal-vs-AfricanAmerican |
8.219400E-01 |
| Normal-vs-Asian |
4.169000E-01 |
| Caucasian-vs-AfricanAmerican |
2.676400E-01 |
| Caucasian-vs-Asian |
3.550200E-01 |
| AfricanAmerican-vs-Asian |
6.708400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.955600E-02 |
| Normal-vs-Female |
2.437600E-02 |
| Male-vs-Female |
7.205800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.714100E-02 |
| Normal-vs-Age(41-60Yrs) |
7.886100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.281520E-02 |
| Normal-vs-Age(81-100Yrs) |
5.595600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.482000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.903400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.840800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.677000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.145200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.493800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.575100E-03 |
| Classical-VS-Follicular |
9.47349999558256E-08 |
| Classical-VS-Other |
1.483000E-01 |
| Classical-VS-Normal |
3.936200E-01 |
| Tall-VS-Follicular |
1.652980E-01 |
| Tall-VS-Other |
7.124600E-01 |
| Tall-VS-Normal |
8.604900E-03 |
| Follicular-VS-Other |
7.509800E-01 |
| Follicular-VS-Normal |
5.70149999999936E-05 |
| Other-VS-Normal |
8.037600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.537200E-03 |
| Normal-vs-N1 |
2.560400E-02 |
| N0-vs-N1 |
9.453400E-01 |
|
|
